Ekaterina Kulchavenya

Prof. Ekaterina Kulchavenya

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Closed access
EKEkaterina Kulchavenya
Ekaterina Kulchavenya
Before discussing the epidemiology of extrapulmonary tuberculosis (EPTB) and particularly urogenital tuberculosis (UGTB), unification of the terminology is necessary. The term ‘urogenital tuberculosis’ is preferable to ‘genitourinary tuberculosis’, as renal and urinary tract tuberculosis is more common than genital tuberculosis. Some understand the term ‘extrapulmonary tuberculosis’ as a specific tuberculosis (TB) lesion of all organs excluding the bronchus, lungs, pleura and intrathoracic bronchopulmonary lymph nodes, but others consider pleural TB as one form of EPTB – and it is a reason for very different proportions in the spectrum of EPTB. Enigmatic tendencies have also been revealed in patients' distribution – in neighbouring regions the incidence rate may differ significantly. Although there is no clear explanation for these tendencies, careful study of the epidemiology of EPTB in different conditions will improve early diagnosis.

19 January 2016 in Pathogens
Verified
Journal Article
Open access
PDF file
FWFlorian Wagenlehner
Florian Wagenlehner
ZTZafer Tandogdu
Zafer Tandogdu
RBRiccardo Bartoletti
Riccardo Bartoletti
Tommaso CaiTommaso Cai
Tommaso Cai
MCMete Cek
Mete Cek
TJtruls erik Bjerklund Johansen
truls erik Bjerklund Johansen
The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence study intended to create surveillance data on antibiotic resistance, type of urogenital infections, risk factors and data on antibiotic consumption, specifically in patients at urological departments with healthcare-associated urogenital infections (HAUTI). Investigators registered data through a web-based application (http://gpiu.esiu.org/). Data collection includes the practice and characteristics of the hospital and urology ward. On a certain day in November, each year, all urological patients present in the urological department at 8:00 a.m. are screened for HAUTI encompassing their full hospital course from admission to discharge. Apart from the GPIU main study, several side studies are taking place, dealing with transurethral resection of the prostate, prostate biopsy, as well as urosepsis. The GPIU study has been annually performed since 2003. Eight-hundred fifty-six urology units from 70 countries have participated so far, including 27,542 patients. A proxy for antibiotic consumption is reflected by the application rates used for antibiotic prophylaxis for urological interventions. Resistance rates of most uropathogens against antibiotics were high, especially with a note of multidrug resistance. The severity of HAUTI is also increasing, 25% being urosepsis in recent years.

21 May 2011 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
EKEkaterina Kulchavenya
Ekaterina Kulchavenya
CKChul-Sung Kim
Chul-Sung Kim
OBOlesya Bulanova
Olesya Bulanova
IZIrina Zhukova
Irina Zhukova

19 March 2013 in Therapeutic Advances in Urology
Verified
Journal Article
Closed access
EKEkaterina Kulchavenya
Ekaterina Kulchavenya
Tuberculosis (TB) is a current public health problem, remaining the most common worldwide cause of mortality from infectious diseases. Urogenital tuberculosis (UGTB) is the second most common form of extrapulmonary TB in countries with severe epidemic situations and the third most common form in regions with a low incidence of TB. In this article we present the terminology, epidemiology and classification of UGTB, as well as describing the laboratory findings and clinical features and approaches to chemotherapy as well as surgery.

17 April 2019 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
EKEkaterina Kulchavenya
Ekaterina Kulchavenya
DKDenis Kholtobin
Denis Kholtobin
SSSergey Shevchenko
Sergey Shevchenko

22 February 2021 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
JAJakhongir Alidjanov
Jakhongir Alidjanov
Tommaso CaiTommaso Cai
Tommaso Cai
RBRiccardo Bartoletti
Riccardo Bartoletti
GBGernot Bonkat
Gernot Bonkat
FBFranck Bruyere
Franck Bruyere
FWFlorian Wagenlehner
Florian Wagenlehner
Purpose: To evaluate and report the complications, and to analyse antimicrobial stewardship aspects following prostate biopsies (P-Bx) based on the data from a 9-year global study.Methods: The primary outcome was to compare complications after P-Bx between patients of two cohorts: 2010–2014 and 2016–2019. Primary outcomes included symptoms of lower and severe/systemic urinary tract infection (LUTIS and SUTIS, respectively), and positive urine culture. Readmission to hospital after P-Bx, need for additional antimicrobial therapy, consumption of different antimicrobial agents for prophylaxis and therapy were evaluated. Studentsttest and chi-square test were used for comparative analyses.Results: Outcome data were available for 1615 men. Fluoroquinolones-based prophylaxis rate increased from 72.0% in 2010–2014 to 78.6% in 2015–2019. Overall rates of complications increased from 6 to 11.7% including an increase in symptomatic complications from 4.7 to 10.2%, mainly due to an increase in LUTIS. Rates of patients seeking additional medical help in primary care after P-Bx increased from 7.4 to 14.4%; cases requiring post P-Bx antibiotic treatment increased from 6.1 to 9.7%, most of which received fluoroquinolones. Transperineal P-Bx was significantly associated with LUTIS. Following transrectal P-Bx, 2.8% developed febrile infections and 4.0% required hospitalisation. Two men (0.12%) died after transrectal P-Bx due to sepsis.Conclusions: The rates of complications after P-Bx tended to increase in time, as well as rates of patients seeking additional medical help in the post-P-Bx period. To reduce the risk of infectious complications and to comply with the principles of antibiotic stewardship, clinicians should switch to the transperineal biopsy route.